OR6T1
gene geneOn this page
Summary
OR6T1 (olfactory receptor family 6 subfamily T member 1, HGNC:14848) is a protein-coding gene on chromosome 11q24.1, encoding Olfactory receptor 6T1 (Q8NGN1). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 219874 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 44 total
- MANE Select transcript:
NM_001005187
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14848 |
| Approved symbol | OR6T1 |
| Name | olfactory receptor family 6 subfamily T member 1 |
| Location | 11q24.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000181499 |
| Ensembl biotype | protein_coding |
| Entrez | 219874 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000321252
RefSeq mRNA: 1 — MANE Select: NM_001005187
NM_001005187
CCDS: CCDS31700
Canonical transcript exons
ENST00000321252 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001262215 | 123942867 | 123943838 |
Expression profiles
Bgee: expression breadth tissue_specific, 7 present calls, max score 46.82.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 46.82 | gold quality |
| colonic epithelium | UBERON:0000397 | 46.21 | gold quality |
| pancreas | UBERON:0001264 | 41.45 | gold quality |
| rectum | UBERON:0001052 | 41.27 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 38.33 | silver quality |
| bone marrow cell | CL:0002092 | 37.97 | gold quality |
| granulocyte | CL:0000094 | 37.05 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 32.67 | gold quality |
| muscle tissue | UBERON:0002385 | 32.27 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| placenta | UBERON:0001987 | 30.02 | gold quality |
| islet of Langerhans | UBERON:0000006 | 29.99 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| calcaneal tendon | UBERON:0003701 | 29.79 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.39 | gold quality |
| leukocyte | CL:0000738 | 29.33 | gold quality |
| corpus callosum | UBERON:0002336 | 29.21 | gold quality |
| monocyte | CL:0000576 | 28.87 | gold quality |
| transverse colon | UBERON:0001157 | 28.77 | silver quality |
| liver | UBERON:0002107 | 28.64 | gold quality |
| adrenal tissue | UBERON:0018303 | 28.63 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 27.93 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 27.16 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.31 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (18): OR6F1 (ENSG00000169214), OR2AP1 (ENSG00000179615), OR6C4 (ENSG00000179626), OR6C2 (ENSG00000179695), OR6S1 (ENSG00000181803), OR6C70 (ENSG00000184954), OR6C76 (ENSG00000185821), OR6C75 (ENSG00000187857), OR6C6 (ENSG00000188324), OR6M1 (ENSG00000196099), OR6C74 (ENSG00000197706), OR6C68 (ENSG00000205327), OR6C65 (ENSG00000205328), OR6C3 (ENSG00000205329), OR6C1 (ENSG00000205330), OR6X1 (ENSG00000221931), OR6V1 (ENSG00000225781), OR6J1 (ENSG00000255804)
Protein
Protein identifiers
Olfactory receptor 6T1 — Q8NGN1 (reviewed: Q8NGN1)
Alternative names: Olfactory receptor OR11-277
All UniProt accessions (1): Q8NGN1
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001005187* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR047132 | Olfact_rcpt_6C-like | Family |
Pfam: PF13853
UniProt features (21 total): topological domain 8, transmembrane region 7, sequence variant 3, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGN1-F1 | 76.29 | 0.22 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 16 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, chr11q24, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
152 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR6T1 | FAM221A | A4D161 | 580 |
| OR6T1 | HEATR9 | A2RTY3 | 542 |
| OR6T1 | C17orf78 | Q8N4C9 | 540 |
| OR6T1 | AMZ1 | Q400G9 | 505 |
| OR6T1 | TERB2 | Q8NHR7 | 474 |
| OR6T1 | CCDC57 | Q2TAC2 | 462 |
| OR6T1 | FASTKD3 | Q14CZ7 | 450 |
| OR6T1 | VCX3A | Q9NNX9 | 444 |
| OR6T1 | STK31 | Q9BXU1 | 431 |
| OR6T1 | FDCSP | Q8NFU4 | 418 |
| OR6T1 | NKAIN4 | Q8IVV8 | 418 |
| OR6T1 | CMYA5 | Q8N3K9 | 408 |
| OR6T1 | RDM1 | Q8NG50 | 401 |
| OR6T1 | MESP2 | Q0VG99 | 400 |
| OR6T1 | KRT75 | O95678 | 391 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR6T1 | PSMD11 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (40): PSMC6 (Affinity Capture-MS), PSMD11 (Affinity Capture-MS), TSPAN10 (Affinity Capture-MS), GUCY1B3 (Affinity Capture-MS), TMEM259 (Affinity Capture-MS), PCYOX1L (Affinity Capture-MS), UBQLN1 (Affinity Capture-MS), EIF2AK3 (Affinity Capture-MS), REEP4 (Affinity Capture-MS), ESYT1 (Affinity Capture-MS), ANKLE2 (Affinity Capture-MS), KCNT2 (Affinity Capture-MS), PKD2 (Affinity Capture-MS), UBQLN4 (Affinity Capture-MS), UBE3A (Affinity Capture-MS)
ESM2 similar proteins: A6ND48, A6NFC9, B2RN74, O43869, O60412, O60431, P23265, P31388, P34987, P47883, P47884, P47887, P58170, Q0VAX9, Q5JRS4, Q60894, Q6IFN5, Q7Z3T1, Q8NG78, Q8NG84, Q8NG94, Q8NG99, Q8NGC0, Q8NGC1, Q8NGC5, Q8NGE7, Q8NGG2, Q8NGG3, Q8NGN1, Q8NGN2, Q8NGR1, Q8NGR2, Q8NGR6, Q8NGT2, Q8NGW1, Q8NGW6, Q8NGZ2, Q8NGZ5, Q8NH06, Q8NH07
Diamond homologs: A6NCV1, A6NDL8, A6NF89, A6NIJ9, A6NJZ3, A6NL08, A6NL26, A6NM76, O76001, O76002, O76100, O95007, P0C623, P0C626, P23266, P23267, P23272, P23274, P30953, P30955, P34985, P58173, P59922, P70526, Q13606, Q5TZ20, Q60882, Q60890, Q6UXT6, Q7TQQ0, Q7Z3T1, Q8N146, Q8N148, Q8N162, Q8N628, Q8NGA1, Q8NGC5, Q8NGE1, Q8NGE2, Q8NGE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
44 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 42 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
291 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:123943601:TGGGA:T | donor_gain | 0.9100 |
| 11:123943809:TGTTA:T | donor_loss | 0.7600 |
| 11:123943810:GTTAC:G | donor_loss | 0.7600 |
| 11:123943811:TTA:T | donor_loss | 0.7600 |
| 11:123943812:TA:T | donor_loss | 0.7600 |
| 11:123943813:AC:A | donor_loss | 0.7600 |
| 11:123943814:C:A | donor_loss | 0.7600 |
| 11:123943723:GCT:G | acceptor_gain | 0.7300 |
| 11:123943815:C:A | donor_loss | 0.7300 |
| 11:123943648:C:CT | acceptor_gain | 0.7100 |
| 11:123943156:GCCCT:G | acceptor_gain | 0.6800 |
| 11:123943724:C:A | acceptor_gain | 0.6400 |
| 11:123943607:C:CT | donor_gain | 0.5900 |
| 11:123943613:CAG:C | donor_gain | 0.5900 |
| 11:123943517:C:CC | acceptor_gain | 0.5800 |
| 11:123943615:G:C | donor_gain | 0.5800 |
| 11:123943648:C:T | acceptor_gain | 0.5800 |
| 11:123943662:CAT:C | donor_gain | 0.5800 |
| 11:123943157:CCCT:C | acceptor_gain | 0.5300 |
| 11:123943422:A:C | donor_gain | 0.5300 |
| 11:123943621:A:T | donor_gain | 0.5100 |
| 11:123943167:A:T | acceptor_gain | 0.5000 |
| 11:123943244:C:CT | donor_gain | 0.5000 |
| 11:123943614:AGT:A | donor_gain | 0.5000 |
| 11:123943159:C:CC | acceptor_gain | 0.4900 |
| 11:123943155:GGCCC:G | acceptor_gain | 0.4500 |
| 11:123943155:GGCC:G | acceptor_gain | 0.4400 |
| 11:123943243:G:C | donor_gain | 0.4400 |
| 11:123943156:GCC:G | acceptor_gain | 0.4300 |
| 11:123943157:CCC:C | acceptor_gain | 0.4300 |
AlphaMissense
2090 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:123942969:G:C | F290L | 0.781 |
| 11:123942969:G:T | F290L | 0.781 |
| 11:123942971:A:G | F290L | 0.781 |
| 11:123943335:G:C | F168L | 0.768 |
| 11:123943335:G:T | F168L | 0.768 |
| 11:123943337:A:G | F168L | 0.768 |
| 11:123943125:A:C | F238L | 0.724 |
| 11:123943125:A:T | F238L | 0.724 |
| 11:123943127:A:G | F238L | 0.724 |
| 11:123943803:A:C | F12L | 0.711 |
| 11:123943803:A:T | F12L | 0.711 |
| 11:123943805:A:G | F12L | 0.711 |
| 11:123943788:G:C | F17L | 0.710 |
| 11:123943788:G:T | F17L | 0.710 |
| 11:123943790:A:G | F17L | 0.710 |
| 11:123942975:G:C | F288L | 0.685 |
| 11:123942975:G:T | F288L | 0.685 |
| 11:123942977:A:G | F288L | 0.685 |
| 11:123943308:G:C | F177L | 0.672 |
| 11:123943308:G:T | F177L | 0.672 |
| 11:123943310:A:G | F177L | 0.672 |
| 11:123943755:G:C | F28L | 0.644 |
| 11:123943755:G:T | F28L | 0.644 |
| 11:123943757:A:G | F28L | 0.644 |
| 11:123943503:G:C | F112L | 0.642 |
| 11:123943503:G:T | F112L | 0.642 |
| 11:123943505:A:G | F112L | 0.642 |
| 11:123943068:A:C | F257L | 0.636 |
| 11:123943068:A:T | F257L | 0.636 |
| 11:123943070:A:G | F257L | 0.636 |
dbSNP variants (sampled 300 via entrez): RS1003324950 (11:123945789 T>G), RS1003388788 (11:123945284 A>T), RS1003760422 (11:123944837 T>A), RS1004271177 (11:123942690 G>T), RS1005618264 (11:123945579 T>G), RS1006881694 (11:123943947 A>G), RS1007531591 (11:123944266 G>A), RS1007608679 (11:123944934 A>G), RS1007991074 (11:123943887 T>C), RS1009653384 (11:123942603 C>T), RS1009664334 (11:123942836 C>T), RS1012483420 (11:123945176 A>G), RS1012513565 (11:123944241 T>C), RS1018126721 (11:123944972 A>G), RS1018627098 (11:123942841 A>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004751_11 | Serum uric acid levels in response to allopurinol in gout | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004761 | uric acid measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 3 |
| Benzo(a)pyrene | affects methylation, increases mutagenesis | 2 |
| Grape Seed Proanthocyanidins | affects cotreatment, increases expression | 1 |
| bisphenol S | increases methylation | 1 |
| Amiodarone | increases expression | 1 |
| Cadmium | increases abundance, decreases expression | 1 |
| Catechin | increases expression, affects cotreatment | 1 |
| Valproic Acid | decreases methylation | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.